The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Functional Sugar for Pharmaceutical Market Research Report 2025
Synopsis
This report studies the functional sugar for pharmaceutical; functional sugar refers to oligosaccharide, Inulin and Sugar Alcohols.
The global Functional Sugar for Pharmaceutical market was valued at US$ 133 million in 2023 and is anticipated to reach US$ 174.6 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Functional Sugar for Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Sugar for Pharmaceutical.
Report Scope
The Functional Sugar for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Functional Sugar for Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Sugar for Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FrieslandCampina
Baolingbao
QHT
Beghin Meiji
Nikon Shikuhin KaKo
Ingredion
Nissin-sugar
Yakult
Orafit
Longlive
Taiwan Fructose
YIBIN YATAI
NFBC
Roquette
ADM
Segment by Type
Oligosaccharide
Inulin
Sugar Alcohols
Others
Segment by Application
Pharmaceutical Industries
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Functional Sugar for Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Functional Sugar for Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report studies the functional sugar for pharmaceutical; functional sugar refers to oligosaccharide, Inulin and Sugar Alcohols.
The global Functional Sugar for Pharmaceutical market was valued at US$ 133 million in 2023 and is anticipated to reach US$ 174.6 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Functional Sugar for Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Sugar for Pharmaceutical.
Report Scope
The Functional Sugar for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Functional Sugar for Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Sugar for Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FrieslandCampina
Baolingbao
QHT
Beghin Meiji
Nikon Shikuhin KaKo
Ingredion
Nissin-sugar
Yakult
Orafit
Longlive
Taiwan Fructose
YIBIN YATAI
NFBC
Roquette
ADM
Segment by Type
Oligosaccharide
Inulin
Sugar Alcohols
Others
Segment by Application
Pharmaceutical Industries
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Functional Sugar for Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Functional Sugar for Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Functional Sugar for Pharmaceutical Market Overview
1.1 Product Overview and Scope of Functional Sugar for Pharmaceutical
1.2 Functional Sugar for Pharmaceutical Segment by Type
1.2.1 Global Functional Sugar for Pharmaceutical Market Value Comparison by Type (2024-2030)
1.2.2 Oligosaccharide
1.2.3 Inulin
1.2.4 Sugar Alcohols
1.2.5 Others
1.3 Functional Sugar for Pharmaceutical Segment by Application
1.3.1 Global Functional Sugar for Pharmaceutical Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical Industries
1.3.3 Research
1.4 Global Functional Sugar for Pharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Functional Sugar for Pharmaceutical Revenue 2019-2030
1.4.2 Global Functional Sugar for Pharmaceutical Sales 2019-2030
1.4.3 Global Functional Sugar for Pharmaceutical Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Functional Sugar for Pharmaceutical Market Competition by Manufacturers
2.1 Global Functional Sugar for Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
2.2 Global Functional Sugar for Pharmaceutical Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Functional Sugar for Pharmaceutical Average Price by Manufacturers (2019-2024)
2.4 Global Functional Sugar for Pharmaceutical Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Functional Sugar for Pharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Functional Sugar for Pharmaceutical, Product Type & Application
2.7 Functional Sugar for Pharmaceutical Market Competitive Situation and Trends
2.7.1 Functional Sugar for Pharmaceutical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Functional Sugar for Pharmaceutical Players Market Share by Revenue
2.7.3 Global Functional Sugar for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Functional Sugar for Pharmaceutical Retrospective Market Scenario by Region
3.1 Global Functional Sugar for Pharmaceutical Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Functional Sugar for Pharmaceutical Global Functional Sugar for Pharmaceutical Sales by Region: 2019-2030
3.2.1 Global Functional Sugar for Pharmaceutical Sales by Region: 2019-2024
3.2.2 Global Functional Sugar for Pharmaceutical Sales by Region: 2025-2030
3.3 Global Functional Sugar for Pharmaceutical Global Functional Sugar for Pharmaceutical Revenue by Region: 2019-2030
3.3.1 Global Functional Sugar for Pharmaceutical Revenue by Region: 2019-2024
3.3.2 Global Functional Sugar for Pharmaceutical Revenue by Region: 2025-2030
3.4 North America Functional Sugar for Pharmaceutical Market Facts & Figures by Country
3.4.1 North America Functional Sugar for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Functional Sugar for Pharmaceutical Sales by Country (2019-2030)
3.4.3 North America Functional Sugar for Pharmaceutical Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Functional Sugar for Pharmaceutical Market Facts & Figures by Country
3.5.1 Europe Functional Sugar for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Functional Sugar for Pharmaceutical Sales by Country (2019-2030)
3.5.3 Europe Functional Sugar for Pharmaceutical Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Functional Sugar for Pharmaceutical Market Facts & Figures by Country
3.6.1 Asia Pacific Functional Sugar for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Functional Sugar for Pharmaceutical Sales by Country (2019-2030)
3.6.3 Asia Pacific Functional Sugar for Pharmaceutical Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Functional Sugar for Pharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Functional Sugar for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Functional Sugar for Pharmaceutical Sales by Country (2019-2030)
3.7.3 Latin America Functional Sugar for Pharmaceutical Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Functional Sugar for Pharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Functional Sugar for Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Functional Sugar for Pharmaceutical Sales by Country (2019-2030)
3.8.3 Middle East and Africa Functional Sugar for Pharmaceutical Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Functional Sugar for Pharmaceutical Sales by Type (2019-2030)
4.1.1 Global Functional Sugar for Pharmaceutical Sales by Type (2019-2024)
4.1.2 Global Functional Sugar for Pharmaceutical Sales by Type (2025-2030)
4.1.3 Global Functional Sugar for Pharmaceutical Sales Market Share by Type (2019-2030)
4.2 Global Functional Sugar for Pharmaceutical Revenue by Type (2019-2030)
4.2.1 Global Functional Sugar for Pharmaceutical Revenue by Type (2019-2024)
4.2.2 Global Functional Sugar for Pharmaceutical Revenue by Type (2025-2030)
4.2.3 Global Functional Sugar for Pharmaceutical Revenue Market Share by Type (2019-2030)
4.3 Global Functional Sugar for Pharmaceutical Price by Type (2019-2030)
5 Segment by Application
5.1 Global Functional Sugar for Pharmaceutical Sales by Application (2019-2030)
5.1.1 Global Functional Sugar for Pharmaceutical Sales by Application (2019-2024)
5.1.2 Global Functional Sugar for Pharmaceutical Sales by Application (2025-2030)
5.1.3 Global Functional Sugar for Pharmaceutical Sales Market Share by Application (2019-2030)
5.2 Global Functional Sugar for Pharmaceutical Revenue by Application (2019-2030)
5.2.1 Global Functional Sugar for Pharmaceutical Revenue by Application (2019-2024)
5.2.2 Global Functional Sugar for Pharmaceutical Revenue by Application (2025-2030)
5.2.3 Global Functional Sugar for Pharmaceutical Revenue Market Share by Application (2019-2030)
5.3 Global Functional Sugar for Pharmaceutical Price by Application (2019-2030)
6 Key Companies Profiled
6.1 FrieslandCampina
6.1.1 FrieslandCampina Corporation Information
6.1.2 FrieslandCampina Description and Business Overview
6.1.3 FrieslandCampina Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.1.4 FrieslandCampina Functional Sugar for Pharmaceutical Product Portfolio
6.1.5 FrieslandCampina Recent Developments/Updates
6.2 Baolingbao
6.2.1 Baolingbao Corporation Information
6.2.2 Baolingbao Description and Business Overview
6.2.3 Baolingbao Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baolingbao Functional Sugar for Pharmaceutical Product Portfolio
6.2.5 Baolingbao Recent Developments/Updates
6.3 QHT
6.3.1 QHT Corporation Information
6.3.2 QHT Description and Business Overview
6.3.3 QHT Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.3.4 QHT Functional Sugar for Pharmaceutical Product Portfolio
6.3.5 QHT Recent Developments/Updates
6.4 Beghin Meiji
6.4.1 Beghin Meiji Corporation Information
6.4.2 Beghin Meiji Description and Business Overview
6.4.3 Beghin Meiji Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beghin Meiji Functional Sugar for Pharmaceutical Product Portfolio
6.4.5 Beghin Meiji Recent Developments/Updates
6.5 Nikon Shikuhin KaKo
6.5.1 Nikon Shikuhin KaKo Corporation Information
6.5.2 Nikon Shikuhin KaKo Description and Business Overview
6.5.3 Nikon Shikuhin KaKo Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nikon Shikuhin KaKo Functional Sugar for Pharmaceutical Product Portfolio
6.5.5 Nikon Shikuhin KaKo Recent Developments/Updates
6.6 Ingredion
6.6.1 Ingredion Corporation Information
6.6.2 Ingredion Description and Business Overview
6.6.3 Ingredion Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ingredion Functional Sugar for Pharmaceutical Product Portfolio
6.6.5 Ingredion Recent Developments/Updates
6.7 Nissin-sugar
6.6.1 Nissin-sugar Corporation Information
6.6.2 Nissin-sugar Description and Business Overview
6.6.3 Nissin-sugar Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nissin-sugar Functional Sugar for Pharmaceutical Product Portfolio
6.7.5 Nissin-sugar Recent Developments/Updates
6.8 Yakult
6.8.1 Yakult Corporation Information
6.8.2 Yakult Description and Business Overview
6.8.3 Yakult Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yakult Functional Sugar for Pharmaceutical Product Portfolio
6.8.5 Yakult Recent Developments/Updates
6.9 Orafit
6.9.1 Orafit Corporation Information
6.9.2 Orafit Description and Business Overview
6.9.3 Orafit Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Orafit Functional Sugar for Pharmaceutical Product Portfolio
6.9.5 Orafit Recent Developments/Updates
6.10 Longlive
6.10.1 Longlive Corporation Information
6.10.2 Longlive Description and Business Overview
6.10.3 Longlive Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Longlive Functional Sugar for Pharmaceutical Product Portfolio
6.10.5 Longlive Recent Developments/Updates
6.11 Taiwan Fructose
6.11.1 Taiwan Fructose Corporation Information
6.11.2 Taiwan Fructose Functional Sugar for Pharmaceutical Description and Business Overview
6.11.3 Taiwan Fructose Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Taiwan Fructose Functional Sugar for Pharmaceutical Product Portfolio
6.11.5 Taiwan Fructose Recent Developments/Updates
6.12 YIBIN YATAI
6.12.1 YIBIN YATAI Corporation Information
6.12.2 YIBIN YATAI Functional Sugar for Pharmaceutical Description and Business Overview
6.12.3 YIBIN YATAI Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.12.4 YIBIN YATAI Functional Sugar for Pharmaceutical Product Portfolio
6.12.5 YIBIN YATAI Recent Developments/Updates
6.13 NFBC
6.13.1 NFBC Corporation Information
6.13.2 NFBC Functional Sugar for Pharmaceutical Description and Business Overview
6.13.3 NFBC Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.13.4 NFBC Functional Sugar for Pharmaceutical Product Portfolio
6.13.5 NFBC Recent Developments/Updates
6.14 Roquette
6.14.1 Roquette Corporation Information
6.14.2 Roquette Functional Sugar for Pharmaceutical Description and Business Overview
6.14.3 Roquette Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Roquette Functional Sugar for Pharmaceutical Product Portfolio
6.14.5 Roquette Recent Developments/Updates
6.15 ADM
6.15.1 ADM Corporation Information
6.15.2 ADM Functional Sugar for Pharmaceutical Description and Business Overview
6.15.3 ADM Functional Sugar for Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ADM Functional Sugar for Pharmaceutical Product Portfolio
6.15.5 ADM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Functional Sugar for Pharmaceutical Industry Chain Analysis
7.2 Functional Sugar for Pharmaceutical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Functional Sugar for Pharmaceutical Production Mode & Process
7.4 Functional Sugar for Pharmaceutical Sales and Marketing
7.4.1 Functional Sugar for Pharmaceutical Sales Channels
7.4.2 Functional Sugar for Pharmaceutical Distributors
7.5 Functional Sugar for Pharmaceutical Customers
8 Functional Sugar for Pharmaceutical Market Dynamics
8.1 Functional Sugar for Pharmaceutical Industry Trends
8.2 Functional Sugar for Pharmaceutical Market Drivers
8.3 Functional Sugar for Pharmaceutical Market Challenges
8.4 Functional Sugar for Pharmaceutical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
